Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment
about
Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.Cutaneous Manifestations of Human and Murine LeishmaniasisLeishmaniasis in the Sudan: a literature review with emphasis on clinical aspects.Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patientsA Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan - A Retrospective Cohort StudyThe role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity.Treatment-based strategy for the management of post-kala-azar dermal leishmaniasis patients in the Sudan.Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasisUse of PCR for diagnosis of post-kala-azar dermal leishmaniasis.Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study.Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in EthiopInterleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese populationLeishmaniasis in Sudan. Post kala-azar dermal leishmaniasis.Pathology of post-kala-azar dermal leishmaniasis: a light microscopical, immunohistochemical, and ultrastructural study of skin lesions and draining lymph nodes.Report of the Post Kala-azar Dermal Leishmaniasis (PKDL) Consortium Meeting, New Delhi, India, 27-29 June 2012.Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.Misdiagnosis and mistreatment of post-kala-azar dermal leishmaniasis.Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL).Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile.Infection rates with Leishmania donovani and Mycobacterium tuberculosis in a village in eastern Sudan.Genetic fingerprinting and identification of differentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis.Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment.The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC)High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasisPost-kala-azar dermal leishmaniasis in NepalVisceral Leishmaniasis - Current Treatments and Needs
P2860
Q31404977-AC0A5B37-7774-418D-B0EB-3D4B4B7FC296Q33839048-F672B0DF-E083-49B7-8F20-13C4A35D21B2Q34037916-4C759D88-7BAF-4393-BA64-CD78F8CEBB06Q34695532-652EB677-A766-415F-996A-1A50F972373DQ36141411-43C4FFC9-532A-4542-BD5C-E3EC4CCFF26EQ36370082-CA721343-3229-4968-A4D5-1B6E7597424FQ36399862-7CB62568-85E3-4C5C-8B7E-9B4DE1CC98ABQ38108301-06C794E3-7A77-465E-8317-1539CF371F23Q39245966-88C0FDDA-D7D0-40A8-AFE6-22A5EB945513Q39554070-E470E501-159A-40A0-BCE1-AD37F9815A4BQ41461856-94FE1D47-A501-4226-8BBE-8591E2554BF9Q41787486-9458395B-4AD5-4D14-BA61-F32532842BE9Q41830302-646FAC9C-73E1-4B88-A8E1-E420A17890A9Q42504757-36C8F7A6-0B44-400F-A9DD-D80FC5C3261BQ42505742-7A455323-7F00-41E1-9D86-25B046573DAFQ42537676-09D292E2-440F-49BE-A4DD-64190034CA5FQ42721940-08F14BC1-5F8C-4080-ADFA-15555D9245AAQ43226918-EE74F4F1-6CD3-418F-BBB9-3A05B05AC99FQ44884159-B79FD99C-5A89-4542-B471-69C7F08FFE7EQ46403854-CB8DC324-8ED5-4E9E-AA35-1138BEBAF441Q46523934-6E3321D6-54CC-494F-952D-05592F3FFD7FQ48077921-AC00D124-3289-4B78-9373-7FAF505FA2BAQ51902268-8AAD8867-37ED-4B77-8477-796563293239Q57633695-3C873BCB-63EF-4B04-8B84-FB75B52198B7Q57633729-BA4E67EA-B45A-46A5-911D-8DBAB3E51F9FQ58850605-7C46A470-5D30-4407-A2CF-63D194B212C1Q59003562-8BA419CC-3F32-47A6-BDAC-3E6AC0E95B08
P2860
Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment
description
1992 nî lūn-bûn
@nan
1992 թուականին հրատարակուած գիտական յօդուած
@hyw
1992 թվականին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Post kala-azar dermal leishman ...... tures, pathology and treatment
@ast
Post kala-azar dermal leishman ...... tures, pathology and treatment
@en
Post kala-azar dermal leishman ...... tures, pathology and treatment
@nl
type
label
Post kala-azar dermal leishman ...... tures, pathology and treatment
@ast
Post kala-azar dermal leishman ...... tures, pathology and treatment
@en
Post kala-azar dermal leishman ...... tures, pathology and treatment
@nl
prefLabel
Post kala-azar dermal leishman ...... tures, pathology and treatment
@ast
Post kala-azar dermal leishman ...... tures, pathology and treatment
@en
Post kala-azar dermal leishman ...... tures, pathology and treatment
@nl
P2093
P921
P3181
P1476
Post kala-azar dermal leishman ...... tures, pathology and treatment
@en
P2093
A M el Hassan
E E Zijlstra
H W Ghalib
I A Eltoum
P3181
P356
10.1016/0035-9203(92)90294-M
P407
P577
1992-01-01T00:00:00Z